The effect of cisplatin dose administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

被引：2
|
作者：
Loong, H. H. F.
Ma, B.
Mo, F.
Leung, S. F.
Hui, E. P.
Kam, M. K.
Chan, S. L.
Chan, A. T. C.
机构：
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Clin Oncol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China
[4] CUHK, Sir YK Pao Ctr Canc, Hong Kong Canc Inst, Shatin, Hong Kong, Peoples R China
[5] CUHK, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5532
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effect of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy on nutritional status in locoregionally advanced nasopharyngeal carcinoma patients: A prospective observational study.
    Miao, Jingjing
    Hu, Chaosu
    Lin, Shaojun
    Chen, Xiaozhong
    Chen, Yuan Yuan
    Zhong, Yahua
    Jin, Feng
    Lin, Qin
    Hu, Xuefeng
    Zhang, Ning
    Wang, Rensheng
    Wang, Lin
    Wang, Cong
    Zhu, Manyi
    Wu, Haijun
    Di, Muping
    Huang, Yuqing
    Xie, Conghua
    Zhao, Chong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Durable response of tislelizumab plus cisplatin, nab-paclitaxel followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A case report
    Tang, Haifeng
    Yang, Donghong
    Luo, Guoqing
    He, Jiaqi
    Yi, Guihua
    Chen, Zihong
    Li, Haiwen
    Luo, Qianbing
    Huang, Ningxin
    Luo, Haiqing
    MEDICINE, 2023, 102 (07) : E32924
  • [43] A potential survival impact of blood immune cells in patients with locoregionally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.
    Yang, Li
    Xu, Zhiyuan
    Lee, Victor Ho-Fun
    Lee, Anne W. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
    Chen, Lei
    Hu, Chao-Su
    Chen, Xiao-Zhong
    Hu, Guo-Qing
    Cheng, Zhi-Bin
    Sun, Yan
    Li, Wei-Xiong
    Chen, Yuan-Yuan
    Xie, Fang-Yun
    Liang, Shao-Bo
    Chen, Yong
    Xu, Ting-Ting
    Li, Bin
    Long, Guo-Xian
    Wang, Si-Yang
    Zheng, Bao-Min
    Guo, Ying
    Sun, Ying
    Mao, Yan-Ping
    Tang, Ling-Long
    Chen, Yu-Ming
    Liu, Meng-Zhong
    Ma, Jun
    LANCET ONCOLOGY, 2012, 13 (02): : 163 - 171
  • [45] Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas
    Serin, M
    Erkal, HS
    Çakmak, A
    ACTA ONCOLOGICA, 1999, 38 (08) : 1031 - 1035
  • [46] Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China
    Zang, Jian
    Xu, Man
    Li, Chen
    Zhao, Lina
    Luo, Shanuan
    Wang, Jianhua
    Shi, Mei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2369 - 2378
  • [47] Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China
    Jian Zang
    Man Xu
    Chen Li
    Lina Zhao
    Shanuan Luo
    Jianhua Wang
    Mei Shi
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2369 - 2378
  • [48] A phase II study of concurrent nimotuzumab and intensity-modulated radiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma.
    Cao, Caineng
    Hu, Qiaoying
    Chen, Xiaozhong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Determining the optimal timing of adjuvant chemotherapy initiation after concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Cheng, H.
    Chen, J.
    Jia, G.
    Liang, Y.
    Li, Y.
    Chen, Y.
    Lin, J.
    Wang, P.
    Chen, Q.
    Tang, L.
    Mai, H.
    Liu, L.
    ESMO OPEN, 2024, 9 (09)
  • [50] Randomized Phase II Trial of Gemcitabine and Cisplatin (GP) versus Docetaxel and Cisplatin (TP) as Induction Chemotherapy followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
    Zang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S106 - S106
12345